Long-term efficacy of the Watchman occlusion device in patients with non valvular atrial fibrillation and contraindications to oral anticoagulants. Data from the Israeli left atrial appendage occluder

Back

ESC Premium Access

Long-term efficacy of the Watchman occlusion device in patients with non valvular atrial fibrillation and contraindications to oral anticoagulants. Data from the Israeli left atrial appendage occluder

Session: Poster session 3 - Anticoagulation in atrial fibrillation III

Topic: Atrial fibrillation (AF)

Speaker: Doctor R. Rosso (Tel Aviv, IL)

Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Raphael Rosso

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

2 presentations

0 follower

24 more presentations in this session

Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin: insights from the ARISTOTLE trial

Speaker: Professor D. Xavier (Bangalore, IN)

Access

Abstract

Slides

Incidence of intracranial hemorrhage in the years 2013-15 in patients with atrial fibrillation in anticoagulant therapy: preliminary analysis of data from Ravenna registers

Speaker: Doctor C. Gatti (Ravenna, IT)

Access

Abstract

Slides

High SAMe-TT2R2 score, labile INR and major adverse outcomes in a real life cohort of anticoagulated patients with non-valvular atrial fibrillation

Speaker: Doctor D. Iglesias (Santiago de Compostela, ES)

Access

Abstract

Slides

CHA2DS2-Vasc score, as well as age and body mass index as the main risk factors of brain lesions in asymptomatic patients with paroxysmal non-valvular atrial fibrillation

Speaker: Doctor J. Wieczorek (Katowice, PL)

Access

Abstract

Slides

Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation

Speaker: Doctor A. Parwani (Berlin, DE)

Access

Abstract

Access the full session

Poster session 3 - Anticoagulation in atrial fibrillation III

Speakers: Doctor R. Rosso, Professor D. Xavier, Doctor C. Gatti, Doctor D. Iglesias, Doctor J. Wieczorek...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

Long-term efficacy of the Watchman occlusion device in patients with non valvular atrial fibrillation and contraindications to oral anticoagulants. Data from the Israeli left atrial appendage occluder

About the speaker

Doctor Raphael Rosso

24 more presentations in this session

Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin: insights from the ARISTOTLE trial

Incidence of intracranial hemorrhage in the years 2013-15 in patients with atrial fibrillation in anticoagulant therapy: preliminary analysis of data from Ravenna registers

High SAMe-TT2R2 score, labile INR and major adverse outcomes in a real life cohort of anticoagulated patients with non-valvular atrial fibrillation

CHA2DS2-Vasc score, as well as age and body mass index as the main risk factors of brain lesions in asymptomatic patients with paroxysmal non-valvular atrial fibrillation

Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation

Access the full session

Poster session 3 - Anticoagulation in atrial fibrillation III

About the event

ESC Congress 2016

ESC 365 is supported by